Cardinal Health Inc. logo

Cardinal Health Inc. (CAH)

Market Closed
15 Jun, 20:00
NYSE NYSE
$
226. 40
+2.55
+1.1392%
$
49.81B Market Cap
164.74 P/E Ratio
2.04% Div Yield
1.76M Volume
5.74 Eps
$ 223.85
Previous Close
Add Transaction
Day Range
221.09 226.6
Year Range
137.75 233.6
Want to track CAH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 6 months ago
Cardinal (CAH) Upgraded to Buy: Here's Why

Cardinal (CAH) Upgraded to Buy: Here's Why

Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 6 months ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 6 months ago
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 6 months ago
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. ( CAH ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thanks for joining us.

Seekingalpha | 7 months ago
4 Value Stocks With Strong Interest Coverage as Markets Rebound

4 Value Stocks With Strong Interest Coverage as Markets Rebound

As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.

Zacks | 7 months ago
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice

Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 7 months ago
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 7 months ago
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?

Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 7 months ago
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 7 months ago
Loading...
Load More